找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases; Christopher L. Cioffi Book 2020 Springer Nature Switzerlan

[复制链接]
查看: 6963|回复: 39
发表于 2025-3-21 17:52:28 | 显示全部楼层 |阅读模式
书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases
编辑Christopher L. Cioffi
视频video
概述Presents the current state of ocular drug therapy.Reviews the unique challenges faced for ocular drug discovery and delivery.Highlights future therapeutic opportunities for age-related macular degener
丛书名称Topics in Medicinal Chemistry
图书封面Titlebook: Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases;  Christopher L. Cioffi Book 2020 Springer Nature Switzerlan
描述.This book reviews the current state of ocular drug therapy and future therapeutic opportunities for a wide variety of conditions, including Age-related Macular Degeneration, Diabetic Retinopathy and Macular Edema, Glaucoma, and Inherited Retinal Diseases..Retinal diseases are major contributors to moderate or severe vision impairment in adults aged 50 years and older. The respective patient populations for many of these indications is expected to significantly increase as the world population continues to grow older. An improved understanding of the etiological underpinnings of ocular degenerative diseases over the past decade has significantly bolstered ophthalmic drug discovery..In this volume, contributions from leading experts explore the unique challenges faced for ocular drug discovery and delivery providing the reader with detailed information on ocular pharmacokinetics, .in vitro, ex vivo. and .in vivo. models for retinal disease pathology and emerginggene therapy treatments. The book is intended for all researchers and clinicians who wish to increase their knowledge on the latest findings in ocular drug therapy..
出版日期Book 2020
关键词Macular Degeneration; Stargardt Disease; Glaucoma; Diabetic Retinopathy; Diabetic Macular Edema; Ocular P
版次1
doihttps://doi.org/10.1007/978-3-030-56619-7
isbn_softcover978-3-030-56621-0
isbn_ebook978-3-030-56619-7Series ISSN 1862-2461 Series E-ISSN 1862-247X
issn_series 1862-2461
copyrightSpringer Nature Switzerland AG 2020
The information of publication is updating

书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases影响因子(影响力)




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases影响因子(影响力)学科排名




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases网络公开度




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases网络公开度学科排名




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases被引频次




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases被引频次学科排名




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases年度引用




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases年度引用学科排名




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases读者反馈




书目名称Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:25:34 | 显示全部楼层
978-3-030-56621-0Springer Nature Switzerland AG 2020
发表于 2025-3-22 03:24:27 | 显示全部楼层
发表于 2025-3-22 05:47:49 | 显示全部楼层
发表于 2025-3-22 09:52:00 | 显示全部楼层
发表于 2025-3-22 14:04:51 | 显示全部楼层
https://doi.org/10.1007/978-3-662-36243-3o major clinical presentations of AMD: atrophic or “dry” and neovascular or “wet.” Geographic atrophy (GA) is the most severe manifestation of dry AMD which represents the form of the disease characterized by the highest prevalence. A smaller fraction of AMD patients (10–20%) develop choroidal neova
发表于 2025-3-22 17:03:15 | 显示全部楼层
发表于 2025-3-22 22:18:26 | 显示全部楼层
发表于 2025-3-23 04:21:14 | 显示全部楼层
https://doi.org/10.1007/978-3-662-36243-3but the number of clinical gene therapy trials has been very limited. The improved visual function outcomes in individuals affected by retinal dystrophy caused by biallelic variants in the RPE65 gene after gene therapy treatment contributed to the US Food and Drug Administration (FDA) and European M
发表于 2025-3-23 06:25:27 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-20 04:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表